_Reagents_Market.JPG)
Global In Vitro Diagnostic (IVD) Reagents Market Size is valued at USD 59.3 Bn in 2024 and is predicted to reach USD 107.2 Bn by the year 2034 at a 6.2% CAGR during the forecast period for 2025-2034.
In vitro diagnostic (IVD) reagents are crucial chemical compounds employed in laboratory analyses to examine samples obtained from the human body, such as blood, urine, and tissue. These substances are essential for the identification of diseases, the surveillance of health, and the execution of medical investigations. In vitro diagnostic (IVD) reagents undergo stringent standardization and quality control measures to guarantee their efficacy and dependability. Health authorities, such as the FDA, enforce regulations on them, requiring them to adhere to rigorous standards. These substances are crucial for facilitating precise medical diagnostics and enhancing healthcare results.
Growing numbers of people afflicted with infectious and chronic diseases are propelling the in vitro diagnostics industry forward. Modern workplaces are witnessing an alarming rising incidence of long-term health problems, including diabetes, cancer, heart disease, and tuberculosis. Infectious diseases, respiratory illnesses, and gastrointestinal issues have all seen significant increases in the number of people affected. The increasing prevalence of these disorders is expected to fuel the demand for diagnostic equipment, which drives the IVD reagents market. With better healthcare infrastructure, increased frequency of long-term health conditions, unmet healthcare needs, and the surge in demand for advanced in vitro diagnostic testing, the in vitro diagnostics reagents market is anticipated to experience significant growth in untapped emerging markets. Furthermore, innovations in in vitro diagnostics are driving the market forward.
However, the market growth is hampered by the strict rules and regulations criteria for the safety and health of the in vitro diagnostic (IVD) reagents market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high IVD because of the Diagnostic reagents are subject to stringent rules that aim to guarantee their safety, effectiveness, and precision throughout their lifecycle. Regional regulatory systems are complicated and ever-changing, necessitating thorough documentation and strict adherence to standards. The market for in-vitro diagnostics has been affected in different ways by the COVID-19 epidemic. Even though the pandemic immediately hampered research and laboratory operations, it ultimately brought attention to the need for RNA-based research and therapies.
The in vitro diagnostic (IVD) reagents market is segmented based on type, technology, Use, and end user. Based on type, the market is segmented into antibodies, purified proteins and peptides, and oligonucleotides. By technology, the market is categorized into immunoassay, clinical chemistry, molecular diagnostics, microbiology, and hematology. By Use, the market is segmented into clinical Use and research use. By end user, the market is segmented into IVD manufacturers, academic institutes & research laboratories, hospital laboratories, and others.
The immunoassay in vitro diagnostic (IVD) reagents market is expected to lead with a major global market share. Immunoassays are vital in the identification of cancer markers, the testing of cardiac biomarkers, and the diagnosis of allergies. Therefore, immunoassay platforms continue to have a high need for specialist IVD reagents since they are the go-to for diagnosticians and clinicians worldwide.
The antibodies are essential in many different types of diagnostic procedures. The ability to accurately detect illnesses, infections, and biomarkers is dependent on these proteins, which are essential parts of immunoassays. Particularly accurate diagnostic results are achieved by monoclonal antibodies due to their tailored high specificity and reproducibility. Their versatility is a result of their adaptability, which includes screening for autoimmune disorders, infectious diseases, and cancer; especially in countries like the US, Germany, the UK, China, and India, there is hope that the current hospital facilities will be improved.
The North American in vitro diagnostic (IVD) reagents market is estimated to record the top market revenue share in the near future. It can be attributed to increasing supportive government policies and a robust diagnostic system. In addition, Asia Pacific is estimated to grow rapidly in the global in vitro diagnostic (IVD) reagents market because of the improvement of healthcare facilities and the increasing presence of many target groups in this region.
|
Report Attribute |
Specifications |
|
Market Size Value In 2024 |
USD 59.3 Bn |
|
Revenue Forecast In 2034 |
USD 107.2 Bn |
|
Growth Rate CAGR |
CAGR of 6.2% from 2025 to 2034 |
|
Quantitative Units |
Representation of revenue in US$ Bn and CAGR from 2025 to 2034 |
|
Historic Year |
2021 to 2024 |
|
Forecast Year |
2025-2034 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Type, Technology, Use, And End User |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; South East Asia; South Korea |
|
Competitive Landscape |
Thermo Fisher Scientific Inc, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc, Agilent Technologies, Inc., QIAGEN N.V., Merck KGaA, Beckman Coulter, Inc, Hologic, Inc, Abcam Ltd, Bio-Techne Corp. SDIX, LLC, RayBiotech, Inc., Sino Biological Inc. and Other Market Players |
|
Customization Scope |
Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global In Vitro Diagnostic (IVD) Reagents Market Snapshot
Chapter 4. Global In Vitro Diagnostic (IVD) Reagents Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2024 & 2034
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Type:
5.2.1. Antibodies
5.2.2. Purified Proteins and Peptides
5.2.3. Oligonucleotides
5.2.4. Others
Chapter 6. Market Segmentation 2: by Technology Estimates & Trend Analysis
6.1. by Technology & Market Share, 2024 & 2034
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Technology:
6.2.1. Immunoassay
6.2.2. Clinical Chemistry
6.2.3. Molecular Diagnostics
6.2.4. Microbiology
6.2.5. Hematology
6.2.6. Others
Chapter 7. Market Segmentation 3: by Use Estimates & Trend Analysis
7.1. by Use & Market Share, 2024 & 2034
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by Use:
7.2.1. Clinical Use
7.2.2. Research Use
7.2.3. Others
Chapter 8. Market Segmentation 4: by End-User Estimates & Trend Analysis
8.1. by End-User & Market Share, 2024 & 2034
8.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2021 to 2034 for the following by End-User:
8.2.1. IVD Manufacturers
8.2.2. Academic Institutes & Research Laboratories
8.2.3. Hospital Laboratories
8.2.4. Others
Chapter 9. In Vitro Diagnostic (IVD) Reagents Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.1.2. North America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.1.3. North America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Use, 2021-2034
9.1.4. North America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.1.5. North America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.2. Europe
9.2.1. Europe In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.2.2. Europe In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.2.3. Europe In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Use, 2021-2034
9.2.4. Europe In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.2.5. Europe In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.3.2. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.3.3. Asia-Pacific In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Use, 2021-2034
9.3.4. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.3.5. Asia Pacific In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.4.2. Latin America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.4.3. Latin America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Use, 2021-2034
9.4.4. Latin America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.4.5. Latin America In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Type, 2021-2034
9.5.2. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Technology, 2021-2034
9.5.3. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by Use, 2021-2034
9.5.4. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034
9.5.5. Middle East & Africa In Vitro Diagnostic (IVD) Reagents Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Thermo Fisher Scientific Inc
10.2.2. Becton, Dickinson and Company
10.2.3. Bio-Rad Laboratories, Inc
10.2.4. Agilent Technologies, Inc.
10.2.5. QIAGEN N.V.
10.2.6. Merck KGaA
10.2.7. Beckman Coulter, Inc
10.2.8. Hologic, Inc
10.2.9. Abcam Ltd
10.2.10. Bio-Techne Corp
10.2.11. InBios International, Inc.
10.2.12. SDIX, LLC
10.2.13. RayBiotech, Inc.
10.2.14. Sino Biological Inc.
10.2.15. Other Prominent Players
In Vitro Diagnostic (IVD) Reagents Market By Type-
In Vitro Diagnostic (IVD) Reagents Market By Technology-
In Vitro Diagnostic (IVD) Reagents Market By Use-
In Vitro Diagnostic (IVD) Reagents Market By End user-
In Vitro Diagnostic (IVD) Reagents Market By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.
Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.
Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.
Secondary research
The secondary research sources that are typically mentioned to include, but are not limited to:
The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista
Primary Research:
Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies
The contributors who typically take part in such a course include, but are not limited to:
Data Modeling and Analysis:
In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.
The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.
To know more about the research methodology used for this study, kindly contact us/click here.
